PFA Pension Forsikringsaktieselskab Purchases Shares of 40,456 Axon Enterprise, Inc $AXON

PFA Pension Forsikringsaktieselskab purchased a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 40,456 shares of the biotechnology company’s stock, valued at approximately $23,145,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Vicus Capital boosted its position in Axon Enterprise by 3.7% in the 3rd quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 14 shares during the period. Evergreen Capital Management LLC boosted its position in Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after buying an additional 15 shares during the period. NorthCrest Asset Manangement LLC boosted its position in Axon Enterprise by 5.4% in the 3rd quarter. NorthCrest Asset Manangement LLC now owns 313 shares of the biotechnology company’s stock valued at $223,000 after buying an additional 16 shares during the period. WPG Advisers LLC boosted its position in Axon Enterprise by 9.8% in the 3rd quarter. WPG Advisers LLC now owns 190 shares of the biotechnology company’s stock valued at $136,000 after buying an additional 17 shares during the period. Finally, Monte Financial Group LLC boosted its position in Axon Enterprise by 5.5% in the 3rd quarter. Monte Financial Group LLC now owns 325 shares of the biotechnology company’s stock valued at $233,000 after buying an additional 17 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the sale, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. The trade was a 0.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Jennifer H. Mak sold 1,500 shares of Axon Enterprise stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the sale, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. This trade represents a 10.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 13,855 shares of company stock worth $7,109,828. 5.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have commented on the stock. Weiss Ratings cut shares of Axon Enterprise from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, April 10th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Royal Bank Of Canada decreased their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research report on Wednesday, February 25th. The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $720.00 to $625.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Finally, TD Cowen decreased their price objective on shares of Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Sixteen research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $749.63.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $402.31 on Monday. The stock has a market cap of $32.41 billion, a P/E ratio of 264.68, a price-to-earnings-growth ratio of 8.59 and a beta of 1.44. The company has a fifty day simple moving average of $454.05 and a 200-day simple moving average of $532.97. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The company’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.08 EPS. Equities analysts expect that Axon Enterprise, Inc will post 1.41 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.